نتایج جستجو برای: سندرم میلودیسپلاستیک mds raeb

تعداد نتایج: 12485  

Journal: :Blood 2001
T Nösslinger R Reisner E Koller H Grüner H Tüchler H Nowotny E Pittermann M Pfeilstöcker

In 1999 a working group of the World Health Organization (WHO) published a revised classification for myelodysplastic syndromes (MDS): RA, RARS, refractory cytopenia with multilineage dysplasia (RC+Dys), RAEB I and II, del (5q) syndrome, and MDS unclassifiable. Chronic myelomonocytic leukemia (CMML) and RAEB-t were excluded. Standard French-American-British (FAB) and new WHO classifications hav...

Journal: :Leukemia research 2009
Katsuya Yamamoto Atsuo Okamura Yoshio Katayama Manabu Shimoyama Toshimitsu Matsui

We describe here two cases of myelodysplastic syndrome (MDS) with a novel unbalanced translocation der(5;19)(p10;q10). Both patients had complex karyotypes including der(5;19) accompanied by an extra chromosome 19, resulting in deletion of the whole long arm of chromosome 5. Furthermore, these patients presented several common clinical and hematological characteristics: MDS subtypes as refracto...

Journal: :Blood 1993
K Sugimoto N Hirano H Toyoshima S Chiba H Mano F Takaku Y Yazaki H Hirai

The p53 gene is currently thought to be a tumor suppressor gene, and its alterations have been suggested to be involved in the pathogenesis of several human malignancies, including some leukemias and lymphomas. We present here evidence for the possible involvement of p53 gene mutations in the myelodysplastic syndrome (MDS), although the incidence is relatively low. Forty-four patients with MDS ...

2011
Valeria Santini Domenico Girelli Alessandro Sanna Nicola Martinelli Lorena Duca Natascia Campostrini Agostino Cortelezzi Michela Corbella Alberto Bosi Gianluigi Reda Oliviero Olivieri Maria Domenica Cappellini

Iron overload may represent an additional clinical problem in patients with Myelodysplastic Syndromes (MDS), with recent data suggesting prognostic implications. Beyond red blood cells transfusions, dysregulation of hepcidin, the key iron hormone, may play a role, but studies until now have been hampered by technical problems. Using a recently validated assay, we measured serum hepcidin in 113 ...

Journal: :Blood 2001
D Y Zang R G Goodwin M R Loken E Bryant H J Deeg

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), a member of the tumor necrosis factor (TNF) family, binds to several cell-surface receptors with distinct functions (agonistic receptors 1 and 2 [TRAIL-R1, TRAIL-R2]; decoy receptors 3 and 4 [TRAIL-R3, TRAIL-R4]). Expression and function was characterized in patients with myelodysplastic syndromes (MDSs). While normal marrow showe...

Journal: :Blood 1992
B Backx L Broeders B Löwenberg

Erythropoiesis in response to erythropoietin (Epo) in myelodysplastic syndrome (MDS) in vitro and in vivo is severely impaired. We investigated the stimulative effect of c-kit ligand (KL) on the erythroid colony-forming abilities of bone marrow cells from 17 patients with MDS. The effects of normal donor-derived marrow were examined in comparison. Suppression of erythroid colony formation in MD...

Journal: :Blood 2002
Olga A Elisseeva Yoshihiro Oka Akihiro Tsuboi Kiyoyuki Ogata Fei Wu Eui Ho Kim Toshihiro Soma Hiroya Tamaki Manabu Kawakami Yusuke Oji Naoki Hosen Takeshi Kubota Masashi Nakagawa Tamotsu Yamagami Akira Hiraoka Machiko Tsukaguchi Keiko Udaka Hiroyasu Ogawa Tadamitsu Kishimoto Taisei Nomura Haruo Sugiyama

Wilms tumor gene WT1 is expressed at high levels in hematopoietic malignancies, such as leukemias and myelodysplastic syndromes (MDS), and in various kinds of solid tumors, including lung cancer, and it exerts an oncogenic function in these malignancies. IgM and IgG WT1 antibodies were measured by means of dot blot assay in 73 patients with hematopoietic malignancies (16 acute myeloid leukemia ...

2002
Kiyoyuki Ogata Kyoko Nakamura Norio Yokose Hideto Tamura Mikiko Tachibana Osamu Taniguchi Rika Iwakiri Tatsuyuki Hayashi Hisashi Sakamaki Yoshiro Murai Kaoru Tohyama Shigeru Tomoyasu Yasunobu Nonaka Mayumi Mori Kazuo Dan Yataro Yoshida

Knowledge of the blast phenotype in myelodysplastic syndromes (MDS) would be valuable, as in other malignancies, but remains sparse. This is mainly because MDS blasts are a minor population in clinical samples, making analysis difficult. Thus, for this blast phenotype study, we prepared blast-rich specimens (using a new density-centrifugation reagent for harvesting blasts) from blood and marrow...

2009
Ying Jiang Andrew Dunbar Lukasz P. Gondek Sanjay Mohan Manjot Rataul Christine O’Keefe Mikkael Sekeres Yogen Saunthararajah P. Maciejewski

Myelodysplastic syndromes (MDSs) are clonal hematologic disorders that frequently represent an intermediate disease stage before progression to acute myeloid leukemia (AML). As such, study of MDS/AML can provide insight into the mechanisms of neoplastic evolution. In 184 patients with MDS and AML, DNA methylation microarray and high-density single nucleotide polymorphism array (SNP-A) karyotypi...

Journal: :Medical principles and practice : international journal of the Kuwait University, Health Science Centre 2009
Abdalla Awidi Ahmad Magableh Ziad Taimeh Hashim Ayyad Nazzal Bsoul Musleh Tarawneh

OBJECTIVE Study of the disease patterns and clinical evaluation of myelodysplastic syndrome (MDS). SUBJECTS AND METHODS A retrospective analysis was carried out on 85 patients, with MDS who were followed up over a period of 23 years at Jordan University Hospital, Amman, Jordan. Cases were analyzed according to the French, American and British Classification. RESULTS Of the 85 patients, 42 (...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید